GAMMA Investing’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$107K Sell
2,609
-446
-15% -$16.9K ﹤0.01% 1757
2026
Q1
$109K Buy
3,055
+616
+25% +$22.4K 0.01% 1601
2025
Q4
$79.1K Buy
2,439
+32
+1% +$999 ﹤0.01% 1744
2025
Q3
$67.9K Sell
2,407
-3,636
-60% -$104K ﹤0.01% 1786
2025
Q2
$182K Buy
6,043
+4,039
+202% +$137K 0.01% 977
2025
Q1
$82K Buy
2,004
+554
+38% +$26.6K 0.01% 1424
2024
Q4
$78.6K Buy
1,450
+1,045
+258% +$59.9K 0.01% 1295
2024
Q3
$26.3K Buy
405
+214
+112% +$13.7K ﹤0.01% 1939
2024
Q2
$11.8K Sell
191
-153
-44% -$10.6K ﹤0.01% 2152
2024
Q1
$29.1K Buy
344
+29
+9% +$2.3K 0.01% 1392
2023
Q4
$23.8K Buy
+315
New +$21.9K 0.01% 1380

Other funds holding CRI

GAMMA Investing's CRI Position: Q2 2026 in Review

GAMMA Investing reduced its Carter's (CRI) stake by 15% in Q2 2026, selling an estimated $16.9K and leaving 2,609 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #1757.

GAMMA Investing first reported a position in CRI in Q4 2023 and has held it in 11 quarters since. The position peaked at $182K in Q2 2025. 42 funds tracked by Wall St. Rank hold CRI as of Q2 2026.

  • GAMMA Investing held 2,609 shares of Carter's worth $107K as of Q2 2026.
  • GAMMA Investing sold 446 Carter's shares in Q2 2026, an estimated $16.9K.
  • Carter's made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #1757 holding.
  • GAMMA Investing first reported a position in Carter's in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Carter's position peaked at $182K in Q2 2025.
  • 42 funds tracked by Wall St. Rank held Carter's as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.